Driven in part by an unusually large number of big-name disappointments, biotech stocks on the whole have been in decline since February – and whether… Read More »Why Biotech’s Trajectory Could Be Determined In June
Thanks largely to their use of covered calls, these five closed-end funds sport very attractive yields. As a result, they may be among the best… Read More »Looking For Income? These 5 Funds Have You Covered
Strong demand for steel has collided with supply shortages across the globe, creating a potential steel supercycle. CLICK HERE.
China is on a mission to overtake the U.S. as the dominant player in the global biotech industry – and that should feed into more… Read More »This ETF Is Positioned To Benefit From The U.S.-China Biotech Battle
In a sea of expensive stocks, here are two under-the-radar dividend growth stocks to put on your radar – the first of which is compelling… Read More »2 Under-The-Radar Dividend Growth Stocks To Put On Your Radar
Are tech stocks a must-own for any winning stock portfolio? One superstar investor shows that’s not necessarily the case. CLICK HERE.
For investors interested in stocks on the way down, these two names are displaying both quantitative and technical deterioration – and could present interesting short… Read More »Opportunities On The Short Side
With the tech-heavy Nasdaq outperforming the S&P 500 and Dow Jones over the past month, and growing investor optimism regarding the tech sector’s ability to… Read More »2 Nasdaq Names Positioned To Soar
With robust growth potential, these seven “cult” stocks are positioned to be the next Tesla in terms of generating outstanding returns for shareholders. CLICK HERE.
Having grown its dividend by 642% over just the past six years, this tech stock – currently available at a solid value – is one… Read More »3 Tech Stocks For Income Investors